DeepMed Research

Abramson Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Employees: -

Market Cap: -

Website: http://www.pennmedicine.org

Clinical Trials

Pre-Transplant INCBB099280 for Hepatocellular Carcinoma (HCC)

Phase 1

Withdrawn

Conditions: Hepatocellular Carcinoma

Interventions: Drug: INCB099280

First Posted Date: 2024-03-29

Last Posted Date: 2024-08-09

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Registration Number: NCT06337162

Locations: 🇺🇸
Abramson Cancer Center at University of Pennsylvania, Philadelphia, Pennsylvania, United States

Effects of Immune Checkpoint Inhibitors on Coronary Microvasculature

Conditions: Coronary Microvascular Dysfunction
Cardiotoxicity
Breast Cancer
Lung Cancer (NSCLC)

First Posted Date: 2024-03-27

Last Posted Date: 2025-01-16

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 25

Registration Number: NCT06332131

Locations: 🇺🇸
Abramson Cancer Center at University of Pennsylvania, Philadelphia, Pennsylvania, United States

Virtual Reality to Promote Relaxation Prior to Simulation

Not Applicable

Completed

Conditions: Cancer

Interventions: Other: Virtual Reality Program

First Posted Date: 2024-03-19

Last Posted Date: 2025-02-28

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 25

Registration Number: NCT06318338

Locations: 🇺🇸
Perelman Center for Advanced Medicine, Philadelphia, Pennsylvania, United States

Social Media Anti-Vaping Messages to Reduce ENDS Use Among Sexual and Gender Minority Teens

Not Applicable

Recruiting

Conditions: Adolescent Behavior
Communication Research
Vaping

Interventions: Other: Tailored

First Posted Date: 2024-03-13

Last Posted Date: 2024-04-12

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 1500

Registration Number: NCT06308081

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

The Role of Flavor in the Substitutability of E-cigarettes for Combustible Cigarettes Among Persistent Smokers

Not Applicable

Recruiting

Conditions: E-Cig Use
Tobacco Use
Cigarette Smoking
Smoking

Interventions: Other: E-cigarettes

First Posted Date: 2024-02-16

Last Posted Date: 2024-10-15

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 210

Registration Number: NCT06264154

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Comparison of Apixaban Versus Enoxaparin

Not Applicable

Conditions: Bladder Cancer

Interventions: Other: enoxaparin
Other: apixaban

First Posted Date: 2024-02-06

Last Posted Date: 2024-10-22

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 90

Registration Number: NCT06243510

Locations: 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

Hypertension and Arrhythmias in CLL Patients Treated with BTK Inhibitors

Conditions: Chronic Lymphocytic Leukemia
Atrial Fibrillation
Hypertension
Cardiotoxicity

First Posted Date: 2024-01-18

Last Posted Date: 2025-03-18

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 50

Registration Number: NCT06211413

Locations: 🇺🇸
Abramson Cancer Center at University of Pennsylvania, Philadelphia, Pennsylvania, United States

Community Support Program for Lung Cancer Screening

Not Applicable

Completed

Conditions: Lung Cancer
Behavior

Interventions: Behavioral: Transportation

First Posted Date: 2024-01-17

Last Posted Date: 2024-11-04

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 26

Registration Number: NCT06207435

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Lipiodol Deposition Using Endhole vs. Pressure-Modulated Delivery

Not Applicable

Active, not recruiting

Conditions: Neuroendocrine Tumors
Hepatocellular Carcinoma

Interventions: Device: TACE Catheters

First Posted Date: 2024-01-12

Last Posted Date: 2025-05-20

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 12

Registration Number: NCT06204159

Locations: 🇺🇸
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸
University of Pennsylvania, Department of Radiology, Interventional Radiology Division, Philadelphia, Pennsylvania, United States

Increasing Screening for Cancer Using EHR-Nudges

Not Applicable

Active, not recruiting

Conditions: Breast Cancer

Interventions: Behavioral: Post-visit patient text messaging
Behavioral: Default pended order
Behavioral: High risk bidirectional post-visit text messaging

First Posted Date: 2023-12-20

Last Posted Date: 2024-12-18

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 21122

Registration Number: NCT06177795

Locations: 🇺🇸
University of Pennsylvania Health System, Philadelphia, Pennsylvania, United States
🇺🇸
Case Western Reserve University/University Hospitals, Cleveland, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy